<PAGE> 1
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------
AMENDMENT NO. 1
TO
FORM 10-KSB
---------------------
(MARK ONE)
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED JUNE 30, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ________ TO ________
COMMISSION FILE NUMBER 0-24913
---------------------
BIOSHIELD TECHNOLOGIES, INC.
(Exact name of small business issuer as specified in its charter)
<TABLE>
<S> <C>
GEORGIA 58-2181628
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
4405 INTERNATIONAL BLVD.
SUITE B-109
NORCROSS, GA 30093
(Address of principal executive office) (Zip Code)
</TABLE>
(770) 925-3432
(Issuer's telephone number, including area code)
SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
<TABLE>
<CAPTION>
NAME OF EACH EXCHANGE
TITLE OF EACH CLASS ON WHICH REGISTERED
- ------------------- ---------------------
<S> <C>
None None
</TABLE>
SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:
Common Stock and Warrants
(Title of Class)
Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days. Yes [X] No [ ]
Check if disclosure of delinquent filers in response to Item 405 of
Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [X]
Issuer's revenues for the fiscal year ended June 30, 1999 were: $305,336.
The aggregate market value of the registrant's voting stock held by
non-affiliates as of June 30, 1999 was: $52,949,400.
The number of shares outstanding of each class of registrant's common stock
as of June 30, 1999 was: Common Stock, par value $0.10 per share, 6,322,315
shares.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant's definitive proxy statement to be furnished to
stockholders in connection with its Annual Meeting of Stockholders to be held on
November 22, 1999 are incorporated by reference in Part III of this Form 10-KSB.
Transitional Small Business Disclosure Format: Yes [ ] No [X]
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BioShield Technologies, Inc.
Date: September 29, 1999 /s/ TIMOTHY C. MOSES
--------------------------------------
TIMOTHY C. MOSES
President and Chief Executive Officer
Date: September 29, 1999 /s/ DANIEL E. SWAYE
--------------------------------------
Daniel E. Swaye
Vice President Finance
(Principal Financial Officer)
